MedTrace Logo

CervIcal Cancer Screening Trial by Randomization of HPV Testing Intervention for Upcoming Screening （CITRUS Study）

NCT01895517 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 18471

Last updated 2023-06-26

No results posted yet for this study

Summary

The aim of this study is to assess efficacy of the screening with concurrent liquid-based cytology and HPV DNA testing for the primary cervical cancer screening over 7 years.

Conditions

Interventions

OTHER

LBC

Cervical cancer screening by using liquid based cytology as a standard screening modality

OTHER

LBC plus HPV DNA testing

Cervical cancer screening by using liquid based cytology plus HPV DNA testing as an experimentally screening modality

Sponsors & Collaborators

  • Keio University

    collaborator OTHER

  • Jikei University School of Medicine

    collaborator OTHER

  • Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
64 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-06-07
Primary Completion
2022-11-30
Completion
2023-05-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01895517 on ClinicalTrials.gov